Literature DB >> 15328421

Assessment of patients with spondyloarthropathies for treatment with tumour necrosis factor alpha blockade.

S Paul1, A Keat.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15328421     DOI: 10.1093/rheumatology/keh358

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  3 in total

1.  Treatment efficacy of etanercept and MTX combination therapy for ankylosing spondylitis hip joint lesion in Chinese population.

Authors:  Fan Lian; Xiuyan Yang; Liuqin Liang; Hanshi Xu; Zhongping Zhan; Qian Qiu; Yujin Ye
Journal:  Rheumatol Int       Date:  2011-03-09       Impact factor: 2.631

Review 2.  Certolizumab pegol: a review of its use in patients with axial spondyloarthritis or psoriatic arthritis.

Authors:  Sohita Dhillon
Journal:  Drugs       Date:  2014-06       Impact factor: 9.546

3.  Etanercept in the treatment of recalcitrant enteropathic arthritis: a case report.

Authors:  Mohd Shahrir Mohamed Said; Sazliyana Shaharir; Sakthiswary Rajalingham; Sheikh Anwar Abdullah; Aizan Bin Hassanudin; Ngiu Chai Soon; Mohd Shahdan Shahid
Journal:  J Med Case Rep       Date:  2012-01-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.